Click here to register free.
Scientific advances in understanding how to manipulate genes to alter the course of disease are now starting to bear fruit. Cell and gene therapies will bring hope to those with conditions once thought to be incurable or irreversible. The webinar will discuss the complex business and political challenges that pioneering life sciences companies face in pricing their products in the United States and around the world. It also will look ahead to the new tools both public and private payers will need to develop in order to ensure appropriate access while keeping an eye on overall budget impacts.